LifeScience

Fivespan Expands Its Portfolio by Acquiring Stake in Life Sciences Leader Qiagen

1 month ago

In a notable move that signals continued momentum in the life sciences sector, Fivespan, a prominent investment firm, has reportedly secured a significant stake in Qiagen, a leading provider of sample and assay technologies. This strategic investment is expected to bolster Fivespan's influence in the rapidly evolving field of biotechnology and diagnostics.

Siemens Poised to Acquire Insight-Backed Dotmatics in Strategic Move

2 months ago

In a significant development within the technology and industrial sectors, Siemens is reportedly on the verge of finalizing a deal to acquire Dotmatics, a company that has garnered substantial backing from Insight Partners. This acquisition highlights Siemens’ continuing commitment to enhance its digital capabilities in the life sciences field, particularly amidst ongoing shifts in how research and development processes are evolving.

Salesforce Steps Up Competition with Veeva by Targeting Pharmaceutical Customers

5 months ago

In a bold move to strengthen its foothold in the pharmaceutical sector, Salesforce has recently intensified its efforts to attract drug manufacturers away from its primary competitor, Veeva Systems. This strategic maneuver comes in light of Salesforce's ambitious plans to expand its offerings tailored specifically for the pharmaceutical industry, capitalizing on a growing demand for innovative customer relationship management solutions.

Merck KGaA Surpasses Expectations Driven by Life Science Segment Growth

6 months ago

Merck KGaA, a globally recognized science and technology company, has reported better-than-expected financial results for the third quarter of 2024, attributing much of its success to a significant surge in its life science division. The company’s earnings indicate a robust performance that is likely to capture the attention of investors keen on biopharmaceuticals and lab technologies.